EHR Company In $3.8M Kickback Settlement

Rivkin Radler LLP
Contact

Rivkin Radler LLP

The U.S. Department of Justice recently announced that CareCloud Health, a Florida-based developer of electronic health records software, agreed to pay $3.8 million to resolve a whistleblower’s allegations that it paid illegal kickbacks to generate sales of its products. CareCloud’s marketing referral program called the “Champions Program” allegedly violated the federal Anti-Kickback Statute (AKS) and False Claims Act (FCA) by paying clients to recommend the company’s EHR products to prospective clients.

The alleged kickback scheme was in operation from 2012 to 2017. A former CareCloud manager filed a qui tam (whistleblower) lawsuit disclosing the scheme and will receive about $800,000 of the settlement amount. The United States intervened in the suit, alleging that CareCloud’s payments violated the AKS and, because the kickbacks rendered false certain claims that were made under federal incentive payment programs, the FCA was triggered as well.

CareCloud did not admit wrongdoing but accepted the settlement in order to “avoid costly litigation.” The company has discontinued the offending marketing referral program.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Rivkin Radler LLP | Attorney Advertising

Written by:

Rivkin Radler LLP
Contact
more
less

Rivkin Radler LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.